Skip to main content

Table 4 Multivariate Analysis

From: Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis

Logistic Regression

Sample Size (N = 4,752)

Persistence at 12 months: Measure 1

Persistence at 12 months: Measure 2

 

OR (95% CI)

p-value

OR (95% CI)

p-value

Female

0.96 (0.83, 1.12)

0.62

0.94 (0.84, 1.06)

0.33

Age < 35

1.04 (0.60, 1.81)

0.89

1.02 (0.64, 1.62)

0.94

Age 35-44

1.06 (0.78, 1.43)

0.72

0.94 (0.73, 1.21)

0.62

Age 55-64

0.96 (0.79, 1.17)

0.69

0.97 (0.83, 1.14)

0.70

Age 65-74

0.73 (0.57, 0.92)

0.01

0.82 (0.68, 0.99)

0.03

Age >74

0.63 (0.48, 0.83)

0.00

0.81 (0.65, 0.99)

0.04

Region: North Central

0.84 (0.64, 1.10)

0.20

0.85 (0.68, 1.06)

0.15

Region: South

0.85 (0.65, 1.11)

0.24

0.81 (0.65, 1.01)

0.06

Region: West

0.80 (0.60, 1.07)

0.13

0.81 (0.64, 1.02)

0.07

Region: Unknown

0.31 (0.07, 1.33)

0.12

0.42 (0.17, 1.02)

0.06

Rural

1.26 (1.05, 1.52)

0.01

1.12 (0.97, 1.31)

0.13

Capitated Insurance

1.18 (0.98, 1.43)

0.08

1.04 (0.89, 1.21)

0.62

Index: Human

0.80 (0.68, 0.95)

0.01

0.77 (0.67, 0.87)

<0.0001

Index: Pen

0.86 (0.68, 1.08)

0.21

0.98 (0.82, 1.17)

0.79

Deyo Charlson Com. Index

0.99 (0.94, 1.04)

0.67

0.97 (0.93, 1.01)

0.11

ER Admissions

1.13 (0.71, 1.81)

0.60

1.18 (0.82, 1.70)

0.37

Inpatient Admissions

0.90 (0.62, 1.31)

0.58

0.95 (0.72, 1.26)

0.73

Diabetes Complications

0.89 (0.74, 1.07)

0.22

0.90 (0.78, 1.04)

0.16

Count of OAD Classes

0.99 (0.96, 1.03)

0.60

1.04 (1.01, 1.06)

0.01

Macrovascular Complications

1.03 (0.87, 1.21)

0.75

0.89 (0.78, 1.01)

0.08

Mental Health Disorders

0.76 (0.55, 1.04)

0.08

0.81 (0.64, 1.02)

0.08

Average Copay for Insulin

0.99 (0.98, 0.99)

<0.0001

0.99 (0.99, 0.99)

<0.0001

Reference Groups: Age 45-54, Region: NorthEast, Non-Capitated Insurance

  1. Abbreviation: Com Inex = Comorbidity Index; OAD = oral antidiabetic agents; OR = odds ratio;
  2. CI = Confidence Interval